These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

435 related articles for article (PubMed ID: 15153710)

  • 1. Treatment of beta-thalassemia patients with recombinant human erythropoietin: effect on transfusion requirements and soluble adhesion molecules.
    Chaidos A; Makis A; Hatzimichael E; Tsiara S; Gouva M; Tzouvara E; Bourantas KL
    Acta Haematol; 2004; 111(4):189-95. PubMed ID: 15153710
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recombinant human erythropoietin therapy in a transfusion-dependent beta-thalassemia major patient.
    Makis AC; Chaliasos N; Hatzimichael EC; Bourantas KL
    Ann Hematol; 2001 Aug; 80(8):492-5. PubMed ID: 11563599
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of rHuEPO therapy initiation on soluble adhesion molecule levels in haemodialysis patients.
    Kahraman S; Yilmaz R; Kirkpantur A; Genctoy G; Arici M; Altun B; Erdem Y; Yasavul U; Turgan C
    Nephrology (Carlton); 2005 Jun; 10(3):264-9. PubMed ID: 15958039
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Recombinant erythropoietin in autologous blood donation].
    von Bormann B; Weidler B; Friedrich M; von Andrian-Werburg H
    Anaesthesist; 1991 Jul; 40(7):386-90. PubMed ID: 1928712
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Therapeutic superiority and safety of combined hydroxyurea with recombinant human erythropoietin over hydroxyurea in young β-thalassemia intermedia patients.
    Elalfy MS; Adly AA; Ismail EA; Elhenawy YI; Elghamry IR
    Eur J Haematol; 2013 Dec; 91(6):522-33. PubMed ID: 23927461
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum transferrin receptor levels in patients with thalassemia intermedia during rHuEPO administration.
    Dore F; Bonfigli S; Gaviano E; Pardini S; Longinotti M
    Haematologica; 1996; 81(1):37-9. PubMed ID: 8900849
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antierythropoietin antibodies in thalassemia patients.
    Voulgari PV; Chaidos A; Tzouvara E; Alymara V; Alamanos Y; Drosos AA; Bourantas KL
    Ann Hematol; 2004 Jan; 83(1):22-7. PubMed ID: 14530877
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reduced blood transfusions requirements after allogeneic bone marrow transplantation: results of a randomised, double-blind study with high-dose erythropoietin.
    Klaesson S; Ringdén O; Ljungman P; Lönnqvist B; Wennberg L
    Bone Marrow Transplant; 1994 Apr; 13(4):397-402. PubMed ID: 8019463
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recombinant human erythropoietin β: the effect of weekly dosing on anemia, quality of life, and long-term outcomes in pediatric cancer patients.
    Durmaz O; Demirkaya M; Sevinir B
    Pediatr Hematol Oncol; 2011 Sep; 28(6):461-8. PubMed ID: 21707225
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hydroxyurea-induced hematological response in transfusion-independent beta-thalassemia intermedia: case series and review of literature.
    Ehsani MA; Hedayati-Asl AA; Bagheri A; Zeinali S; Rashidi A
    Pediatr Hematol Oncol; 2009 Nov; 26(8):560-5. PubMed ID: 19954365
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Response to hydroxyurea therapy in beta-thalassemia.
    Koren A; Levin C; Dgany O; Kransnov T; Elhasid R; Zalman L; Palmor H; Tamary H
    Am J Hematol; 2008 May; 83(5):366-70. PubMed ID: 18181203
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Induction of fetal hemoglobin synthesis with recombinant human erythropoietin in anemic patients with heterozygous beta-thalassemia during pregnancy.
    Breymann C; Fibach E; Visca E; Huettner C; Huch A; Huch R
    J Matern Fetal Med; 1999; 8(1):1-7. PubMed ID: 10052837
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Administration of high doses of recombinant human erythropoietin to patients with beta-thalassemia intermedia: a preliminary trial.
    Bourantas K; Economou G; Georgiou J
    Eur J Haematol; 1997 Jan; 58(1):22-5. PubMed ID: 9020369
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Response to hydroxycarbamide in pediatric β-thalassemia intermedia: 8 years' follow-up in Egypt.
    El-Beshlawy A; El-Ghamrawy M; EL-Ela MA; Said F; Adolf S; Abdel-Razek AR; Magdy RI; Abdel-Salam A
    Ann Hematol; 2014 Dec; 93(12):2045-50. PubMed ID: 25062719
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Endothelial dysfunction and inflammatory process in transfusion-dependent patients with beta-thalassemia major.
    Aggeli C; Antoniades C; Cosma C; Chrysohoou C; Tousoulis D; Ladis V; Karageorga M; Pitsavos C; Stefanadis C
    Int J Cardiol; 2005 Oct; 105(1):80-4. PubMed ID: 16207549
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum erythropoietin and circulating transferrin receptor in thalassemia intermedia patients with heterogeneous genotypes.
    Camaschella C; Gonella S; Calabrese R; Vischia F; Roetto A; Graziadei G; Mazza U; Cappellini MD
    Haematologica; 1996; 81(5):397-403. PubMed ID: 8952151
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recombinant human erythropoietin therapy in critically ill patients: a dose-response study [ISRCTN48523317].
    Georgopoulos D; Matamis D; Routsi C; Michalopoulos A; Maggina N; Dimopoulos G; Zakynthinos E; Nakos G; Thomopoulos G; Mandragos K; Maniatis A;
    Crit Care; 2005 Oct; 9(5):R508-15. PubMed ID: 16277712
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reduction of the clinical severity of sickle cell/beta-thalassemia with hydroxyurea: the experience of a single center in Greece.
    Loukopoulos D; Voskaridou E; Kalotychou V; Schina M; Loutradi A; Theodoropoulos I
    Blood Cells Mol Dis; 2000 Oct; 26(5):453-66. PubMed ID: 11112383
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Response to hydroxyurea in beta thalassemia major and intermedia: experience in western India.
    Italia KY; Jijina FJ; Merchant R; Panjwani S; Nadkarni AH; Sawant PM; Nair SB; Ghosh K; Colah RB
    Clin Chim Acta; 2009 Sep; 407(1-2):10-5. PubMed ID: 19545554
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy of erythropoietin on dialysis in patients with beta thalassemia minor.
    Di Iorio B; De Nicola L; Bellizzi V; Minutolo R; Zamboli P; Rubino R; Fuiano G; Conte G
    Blood Purif; 2004; 22(5):453-60. PubMed ID: 15359104
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.